To examine whether ASAP1-IT1 serves as a dominant factor of cisplatin resistance in NSCLC cells, A549 cells with ASAP1-IT1-knockdown were incubated with 4 μM cisplatin. Here, ASAP1 is linked to non-small cell lung carcinoma.